14 Feb, 2024 Life sciences – what to expect in 2024 By Harriet Hanks Emma Franck-Gwinnell Adam Golden 2023 was marked by some real success stories in the life sciences and healthcare space, including ground-breaking new weight loss...
18 Oct, 2023 California’s Delete Act Could Be Next Frontier Beyond CCPA By Christine Lyon Jackson Myers Freshfields’ Christine Lyon and Jackson Myers analyze California’s newly signed Delete Act and how it could affect state residents’...
20 Jul, 2023 Proposed New U.S. Merger Guidelines: Making Old Ideas New Again By Bruce McCulloch Andrew Ewalt Jamillia Ferris Mary Lehner Jennifer Mellott Meghan Rissmiller Jan Rybnicek Justin Stewart-Teitelbaum Laura Onken Timothy Swartz +7 more... Show less The U.S. Department of Justice Antitrust Division (“DOJ”) and Federal Trade Commission (“FTC”) yesterday released a draft of revised...
15 Sep, 2022 Illumina/Grail: A Tale of Transatlantic Entropy By Thomas Lübbig Justin Stewart-Teitelbaum Laura Onken Lauren Vaca Amaryllis Müller Karen Slaney +3 more... Show less This isn’t the first time we’ve written about this US-focused transaction in the innovative markets for next generation gene sequencing...
13 Jan, 2022 Ten key medtech themes for 2022 By Vinita Kailasanath Nida Rais The COVID-19 pandemic has accelerated the transformation of business models in the life sciences industry, with digital initiatives...
05 Feb, 2021 Critical HSR Updates: Suspension of Early Termination and Decrease of HSR Monetary Thresholds in the United States By Meghan Rissmiller Ilana Kattan Valeria Losco This week, the US Federal Trade Commission (FTC) announced two significant changes to the US merger review process: (1) the suspension of...